Anti-ATM 抗体 (ab17995)

ab17995 は 7 報の論文で使用されています。

• Jain N  et al. A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL. Oncotarget 8:22104-22112 (2017). WB ; Human . PubMed: 27655665
• Tanikawa M  et al. The spliceosome U2 snRNP factors promote genome stability through distinct mechanisms; transcription of repair factors and R-loop processing. Oncogenesis 5:e280 (2016). WB ; Human . PubMed: 27991914
• Nanetti L  et al. SETX mutations are a frequent genetic cause of juvenile and adult onset cerebellar ataxia with neuropathy and elevated serum alpha-fetoprotein. Orphanet J Rare Dis 8:123 (2013). WB ; Human . PubMed: 23941260
• Khalil HS  et al. Pharmacological inhibition of ATM by KU55933 stimulates ATM transcription. Exp Biol Med (Maywood) 237:622-34 (2012). PubMed: 22728709
• Colnaghi L  et al. Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair. Blood 117:2247-56 (2011). WB ; Human . PubMed: 20971953
• Dregalla RC  et al. Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs. Aging (Albany NY) 2:691-708 (2010). WB ; Human . PubMed: 21037379
• Shrivastav M  et al. DNA-PKcs and ATM co-regulate DNA double-strand break repair. DNA Repair (Amst) 8:920-9 (2009). PubMed: 19535303